SLA2 and diabetes mellitus: Aberrations in signal transduction are associated with a number of diseases, including cancer, diabetes etc. In this study we identify SLAP2 as a novel KIT interacting protein, which regulates receptor signaling by reducing the activity of its downstream signal transduction targets and by promoting degradation of the receptor.